Skip to main content

GUD · Knight Therapeutics Inc. · Financials

11.5600 CAD +0.2600 (+2.30%) At close · Nov 5 Intraday price with Plus
Market Cap
1.14B CAD
Shares
98.23M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

No Financial Data

No structured financial facts have been ingested for this stock yet.